A new spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Germans Trias i Pujol Research Institute (IGTP) and ICREA has joined the UAB Research Park. The company will develop therapeutic products to fight against autoimmune diseases, such as type 1 diabetes or multiple sclerosis.